Related Experiment Video

Updated: May 19, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Clinical and imaging findings in thalassemia patients with extramedullary hematopoiesis

Guangbin Zhu1, Xiaomei Wu, Xuelin Zhang

  • 1Department of Radiology, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.

Clinical Imaging
|August 28, 2012
PubMed

Insights

Imaging features of thalassemia with extramedullary hematopoiesis were analyzed in 17 patients. Skeletal and nonskeletal manifestations observed in imaging studies can aid in clinical diagnosis.

Area of Science:

  • Radiology
  • Medical Imaging
  • Hematology

Background:

  • Thalassemia is a group of inherited blood disorders.
  • Extramedullary hematopoiesis (EMH) is the formation of blood cells outside the bone marrow.
  • EMH can occur in various organs in patients with thalassemia.

Purpose of the Study:

  • To analyze the imaging features of thalassemia with extramedullary hematopoiesis.
  • To identify characteristic radiological findings associated with EMH in thalassemia patients.
  • To assess the utility of different imaging modalities in diagnosing these conditions.

Main Methods:

  • Retrospective analysis of 17 thalassemia patients with EMH.
  • Review of imaging studies including X-ray, ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI).
  • Correlation of imaging findings with clinical data.

Main Results:

  • Hepatic enlargement observed in 9 cases.
  • Megalocardia or hypodensity noted in 12 cases.
  • Skeletal manifestations were present in 15 cases, commonly affecting ribs, spine, and skull.
  • Nonskeletal manifestations occurred in 5 cases, including cholelithiasis (1 case) and hepatic hemosiderosis (3 cases).
  • EMH was confirmed in 3 cases.

Conclusions:

  • Imaging findings, particularly skeletal and nonskeletal manifestations, are valuable for the clinical diagnosis of thalassemia with extramedullary hematopoiesis.
  • Multimodality imaging plays a crucial role in characterizing EMH in thalassemia.
  • Radiological assessment can guide further clinical management.

More Related Videos

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis11:50

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis

Published on: April 10, 2012

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...